Bracco Diagnostics

Bracco, the parent company of Bracco Diagnostics, was founded in 1927. It has been owned and operated for three generations by the Bracco family. The company is an integrated health care group and a world leader in global solutions for the diagnostic imaging field. Born as a pharmaceuticals trading concern, the company has developed an independent industrial production and research activity, specializing its research and development capacities in a specific field - diagnostic imaging. Bracco's laboratories discovered and developed the iopamidol molecule, the first ready-to-use non-ionic contrast medium. In 1994, the company expanded into the United States. It founded Bracco Diagnostics and Bracco Research USA in Princeton, N.J. The United States represents the group's largest market in the sector of contrast agents for medical diagnostics.

Swiss Orthopedic Co. in Hillsborough, NJ, is recognized as a premier provider of orthotic and prosthetic care, dedicated to breaking down barriers of physical limitations. The company specializes in custom solutions tailored to meet individual orthotic and prosthetic needs. In addition to orthotics and prosthetics, Swiss Orthopedic Co. offers a range of services including orthopedic shoes, shoe modifications, and specialized facemasks for sports and burn victims. Their commitment to patient care is evident in their comprehensive approach to enhancing mobility and quality of life. Generated from the website